Webinar

Two Perspectives: Patient and Hematopathologist Discussion on Importance of CML Monitoring

On-demand

Patients diagnosed with CML 20 years ago could live for around five years. Today CML patients can live everyday life on medication. With patients living longer with this disease, routine CML monitoring is critical to ensure a continued response to treatment.

CML Patients can have an everyday life with a fast and accurate CML Monitoring solution

Cepheid Solution for CML Monitoring (rapid and accurate) at the lab - Xpert® BCR-ABL Ultra

In this webinar, 27-year terminally diagnosed CML survivor Mel Mann, M.B.A., M.Ed, and Dr. Guang Fan, MD, Ph.D., Director of Hematopathology Program at Oregon Health & Science University, will talk about the importance of routine CML Monitoring and the benefits of getting same-day results.

Join us for this exciting and vital discussion on May 24th at 10 am PST.

Webinar Learning Objectives:

  • CML Patient can have a normal life with rapid and fast CML Monitoring solution - BCR ABL ULTRA
  • Cepheid Solution for CML Monitoring (rapid and accurate) at the lab - BCR ABL ULTRA

Mel Mann, MBA, M.Ed.

Major, US Army Retired

World’s Longest Living Gleevec (Imatinib) & TKI & Kinase Inhibitor Survivor, Patient Advocate, 27 Year Terminal CML Leukemia Survivor, Consultant, Guest Speaker, Health Equity, Clinical Trials, U.S. Army Retired.

Guang Fan, MD, PhD

Professor, Department of Pathology and Laboratory Medicine Associate Director of Clinical Laboratory Director, Flow Cytometry Laboratory Director, Hematopathology Program Oregon Health & Science University , Oregon Health & Science University

Dr. Fan is an expert in diagnosis of leukaemia, lymphoma, congenital and acquired bone marrow failure disorders.

Dr. Fan's research interest is in developing sensitive and advanced diagnostic tests for leukaemia and lymphoma.